Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia

Nature Neuroscience

Volumn 7, Issue 6, 2004, Pages 575-580

  Corfas, Gabriel ^a   Roy, Kristine ^a   Buxbaum, Joseph D ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; NEU DIFFERENTIATION FACTOR; NEUROTRANSMITTER RECEPTOR;

CELL MIGRATION; DEVELOPMENTAL DISORDER; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; HUMAN; MOLECULAR BIOLOGY; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; PATHOGENESIS; PREFRONTAL CORTEX; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY;

ANIMALS; HUMANS; NEUREGULIN-1; RECEPTOR, ERBB-3; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 2542451853     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1258     Document Type: Review

References (65)

1. Lewis, D.A. & Levitt, P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci, 25, 409-432 (2002).
2. Lewis, D.A. & Lieberman, J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 28, 325-334 (2000).
3. Tsuang, M.T., Stone, W.S. & Faraone, S.V. Genes, environment and schizophrenia. Br. J. Psychiatry Suppl. 40, s18-24 (2001).
4. Sklar, P. Linkage analysis in psychiatric disorders: the emerging picture. Annu. Rev. Genomics Hum. Genet. 3, 371-413 (2002).
5. Buonanno, A. & Fischbach, G.D. Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr. Opin. Neurobiol. 11, 287-296 (2001).
6. Corfas, G., Rosen, K.M., Aratake, H., Krauss, R. & Fischbach, G.D. Differential expression of ARIA isoforms in the rat brain. Neuron 14, 103-115 (1995).
7. Falls, D.L., Rosen, K.M., Corfas, G., Lane, W.S. & Fischbach, G.D. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell 72, 801-815 (1993).
8. Marchionni, M.A. et al. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362, 312-318 (1993).
9. Rio, C., Rieff, H.I., Qi, P., Khurana, T.S. & Corfas, G. Neuregulin and erbB receptors playa critical role in neuronal migration, Neuron 19, 39-50 (1997).
10. Anton, E.S., Marchionni, M.A., Lee, K.F. & Rakic, P. Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. Development 124, 3501-3510 (1997).
11. Steiner, H., Blum, M., Kitai, S.T. & Fedi, P. Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat. Exp. Neurol. 159, 494-503 (1999).
12. Yau, H.J., Wang, H.F., Lai, C. & Liu, F.C. Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb. Cortex 13, 252-264 (2003).
13. Prevot, V. et al. Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes. J. Neurosci. 23, 230-239 (2003).
14. Liu, Y., Ford, B., Mann, M.A. & Fischbach, G.D. Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J. Neurosci. 21, 5660-5669 (2001).
15. Ozaki, M., Sasner, M., Yano, R., Lu, H.S. & Buonanno, A. Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 390, 691-694 (1997).
16. Okada, M. & Corfas, G. Neuregulin1 down-regulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse. Hippocampus, DOI: 10.1002/hipo.10185 (2003).
17. Stefansson, H. et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892 (2002).
18. Rieff, H.I. et al. Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J. Neurosci. 19, 10757-10766 (1999).
19. Cannella, B., Pitt, D., Marchionni, M. & Raine, C.S. Neuregulin and erbB receptor expression in normal and diseased human white matter. J. Neuroimmunol. 100, 233-242 (1999).
20. Vartanian, T., Fischbach, G. & Miller, R. Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proc. Natl. Acad. Sci. USA 96, 731-735 (1999).
21. Fernandez, P.A. et al. Evidence that axon-derived neuregulin promotes oligodendrocyte survival in the developing rat optic nerve. Neuron 28, 81-90 (2000).
22. Calaora, V. et al. Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J. Neurosci, 121, 4740-4751 (2001).
23. Schmucker, J. et al. erbB3 is dispensable for oligodendrocyte development in vitro and in vivo. Glia 44, 67-75 (2003).
24. Vartanian, T., Corfas, G., Li, Y., Fischbach, G.D. & Stefansson, K. A role for the acetylcholine receptor-inducing protein ARIA in oligodendrocyte development. Proc. Natl. Acad. Sci. USA 91, 11626-11630 (1994).
25. Canoll, P.D. et al. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17, 229-243 (1996).
26. Akbarian, S. et al. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch. Gen. Psychiatry 53, 425-436 (1996).
27. Akbarian, S. et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 16, 19-30 (1996).
28. Rioux, L., Nissanov, J., Lauber, K., Bilker, W.B. & Arnold, S.E. Distribution of microtubule-associated protein MAP2-immunoreactive interstitial neurons in the parahippocampal white matter in subjects with schizophrenia. Am. J. Psychiatry 160, 149-155 (2003).
29. Zavitsanou, K., Ward, P.B. & Huang, X.F. Selective alterations in ionotropic glutamate receptors in the anterior cingulate cortex in schizophrenia. Neuropsychopharmacology 27, 826-833 (2002).
30. Mohn, A.R., Gainetdinov, R.R., Caron, M.G. & Koller, B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427-436 (1999).
31. Huntsman, M.M., Tran, B.V., Potkin, S.G., Bunney, W.E., Jr. & Jones, E.G. Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc. Natl. Acad. Sci. USA 95, 15066-15071 (1998).
32. Hakak, Y. et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA 98, 4746-4751 (2001).
33. Mirnics, K., Middleton, F.A., Marquez, A., Lewis, D.A. & Levitt, P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in pre-frontal cortex. Neuron 28, 53-67 (2000).
34. Volk, D.W., Austin, M.C., Pierri, J.N., Sampson, A.R. & Lewis, D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 57, 237-245 (2000).
35. Volk, D., Austin, M., Pierri, J., Sampson, A. & Lewis, D. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am. J. Psychiatry 158, 256-265 (2001).
36. Uranova, N. et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 55, 597-610 (2001).
37. Tkachev, D. et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798-805 (2003).
38. Hof, P.R., Haroutunian, V., Copland, C., Davis, K.L & Buxbaum, J.D. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem. Res. 27, 1193-1200 (2002).
39. Hof, P.R. et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry 53, 1075-1085 (2003).
40. Bartzokis, G. et al. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol. Psychiatry 53, 412-421 (2003).
41. Flynn, S.W. et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol. Psychiatry 8, 811-820 (2003).
42. Foong, J. et al. Investigating regional white matter in schizophrenia using diffusion tensor imaging. Neuroreport 13, 333-336 (2002).
43. Walker, E. & Bollini, A.M. Pubertal neurodevelopment and the emergence of psychotic symptoms. Schizophr. Res. 54, 17-23 (2002).
44. Freedman, R., Hall, M., Adler, L.E. & Leonard, S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry 38, 22-33 (1995).
45. Court, J. et al. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. J. Neurochem. 73, 1590-1597 (1999).
46. Guan, Z.Z., Zhang, X., Blennow, K. & Nordberg, A. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport 10, 1779-1782 (1999).
47. Stefansson, H. et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am. J. Hum. Genet. 72, 83-87, (2003).
48. Williams, N.M. et al. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol. Psychiatry 8, 485-487 (2003).
49. Lohmueller, K.E., Pearce, C.L., Pike, M., Lander, E.S. & Hirschhorn, J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33, 177-182 (2003).
50. Yang, J.Z. et al. Association study of neuregulin 1 gene with schizophrenia. Mol. Psychiatry 8, 706-709 (2003).
51. Tang, J.X. et al. Polymorphisms within 5′ end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol. Psychiatry 9, 11-12 (2004).
52. Iwata, N. et al. No association with the neuregulin 1 haplotype to Japanese schizophrenia. Mol. Psychiatry 9, 126-127 (2004).
53. Hashimoto, R. et al. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol. Psychiatry 21, 21 (2003).
54. Arnold, S.E. & Trojanowski, J.Q. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol. (Berl) 92, 217-231 (1996).
55. Harrison, P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122, 593-624 (1999).
56. Blum, B.P. & Mann, J.J. The GABAergic system in schizophrenia. Int. J. Neuropsychopharmacol. 5, 159-179 (2002).
57. Konradi, C. & Heckers, S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol. Ther. 97, 153-179 (2003).
58. Benes, F.M. & Berretta, S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25, 1-27 (2001).
59. Bartzokis, G. Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology 27, 672-683 (2002).
60. Davis, K.L. et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 60, 443-456 (2003).
61. Pongrac, J., Middleton, F.A., Lewis, D.A., Levitt, P. & Mirnics, K. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem. Res, 27, 1049-1063 (2002).
62. Moises, H.W., Zoega, T. & Gottesman, II. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2, 8 (2002).
63. Hakola, H.P. Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia. Acta Psychiatr. Scand. Suppl. 232, 1-173 (1972).
64. Friston, K.J. & Frith, C.D. Schizophrenia: a disconnection syndrome? Clin. Neurosci. 3, 89-97 (1995).
65. Cannon, T.D. et al. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch. Gen. Psychiatry 55, 1084-1091 (1998).